Please login to the form below

Not currently logged in
Email:
Password:

McCann Echo strengthens leadership team

Promotes Jesse Johanson as its president

Jesse JohansonMcCann Echo, a speciality unit of McCann Health, has promoted Jesse Johanson from his previous role as executive vice president, director of strategic planning to president.

He said: “It’s an honour to take the helm at McCann Echo and partner with such a terrific senior management team.

“I look forward to building on their tremendous growth and creative output and to continuing to help our clients successfully navigate the complexities of today’s rapidly changing marketplace.”

Johanson was also named on the 2017 PharmaVoice 100, which recognises inspiring individuals in the life sciences industry.

Amar Urhekar, president of McCann Health Americas, said: “Jesse is an exceptional talent has done an outstanding job of expanding the scientific and strategic capabilities at McCann Echo.

“I’m confident that Jesse will lead McCann Echo to new heights of growth and success and I look forward to welcoming him to the executive leadership team.”

31st August 2017

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

How innovating study sites can improve patient recruitment efficiency
There are so many ways that clinical trials have innovated over the last few years. There is now a larger focus on making trials more patient-centric, more virtualised, and more...
PME-MAY21-Cover
Avoiding A Series of Unfortunate Events: launch lessons from lockdown
Chris Ross takes a novel look at launch excellence through the lens of COVID-19 and explores how pharma’s launch leaders are rewriting the story...
6 reasons patients drop out of clinical trials and 6 ways to fix it
If you’ve successfully recruited patients for your clinical trial, but one by one, they begin to drop out, then this information could be for you....